视觉评估[18F]氟美他莫PET图像可检测早期淀粉样蛋白病理并分级其范围
本研究纳入497例受试者的[18F]氟美他莫PET图像,按产品指南进行视觉阅读(VR),记录阳性区域数(0-5)及最终阴性/阳性分类,并与Centiloid(CL)定量及尸检神经病理分类比较。VR与CL=12和CL=30切点高度一致,ROC分析得出最佳CL=17切点(敏感度97.9%,特异度97.8%),每个额外阳性VR区域对应全局CL明显增加,提示VR适用于评估早期淀粉样蛋白病理并可分级视觉阳性范围。
要点
- VR对应的最佳CL切点为17,敏感度97.9%、特异度97.8%。
- 每增加一个阳性VR区域,全局CL明显增加,提示可分级阳性范围。
核心结论
- 视觉阅读是评估早期淀粉样蛋白病理的合适方法,分级视觉阳性范围可能具有临床价值。
研究设计与样本
- 纳入497例受试者(ALFA+ N=352;ADC N=145)的[18F]氟美他莫PET图像,按产品指南进行视觉评估并记录阳性区域数(0-5)及最终分类,同时用标准与区域Centiloid方法定量,另纳入28例尸检病例比较视觉阅读与神经病理分类。
主要发现
- ROC分析得出VR对应的最佳CL=17切点,敏感度97.9%、特异度97.8%。
- 每个额外阳性VR区域对应全局CL明显增加,区域VR也与区域CL定量相关。
- 与mCERADSOT分类(任何区域mCERADSOT>1.5)比较,VR一致率89.3%,其中真阴性13例、真阳性12例、假阳性3例。
- 3例假阳性均观察到区域稀疏至中等神经炎性和大量弥漫Aβ斑块,区域VR与区域斑块密度相关。
关键数值与推荐
- VR对应的最佳CL=17切点:敏感度97.9%,特异度97.8%。
- 与mCERADSOT分类(任何区域mCERADSOT>1.5)比较,VR一致率89.3%(真阴性13例、真阳性12例、假阳性3例)。
临床怎么用
- 可按产品指南对[18F]氟美他莫PET进行视觉阅读并记录阳性区域数以分级淀粉样蛋白阳性范围。
- 视觉阅读可用于检测早期淀粉样蛋白病理,与Centiloid定量切点高度一致。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To investigate the sensitivity of visual read (VR) to detect early amyloid pathology and the overall utility of regional VR. METHODS: [18F]Flutemetamol PET images of 497 subjects (ALFA+ N = 352; ADC N = 145) were included. Scans were visually assessed according to product guidelines, recording the number of positive regions (0-5) and a final negative/positive classification. Scans were quantified using the standard and regional Centiloid (CL) method. The agreement between VR-based classification and published CL-based cut-offs for early (CL = 12) and established (CL = 30) pathology was determined. An optimal CL cut-off maximizing Youden's index was derived. Global and regional CL quantification was compared to VR. Finally, 28 post-mortem cases from the [18F]flutemetamol phase III trial were included to assess the percentage agreement between VR and neuropathological classification of neuritic plaque density. RESULTS: VR showed excellent agreement against CL = 12 (κ = .89, 95.2%) and CL = 30 (κ = .88, 95.4%) cut-offs. ROC analysis resulted in an optimal CL = 17 cut-off against VR (sensitivity = 97.9%, specificity = 97.8%). Each additional positive VR region corresponded to a clear increase in global CL. Regional VR was also associated with regional CL quantification. Compared to mCERADSOT-based classification (i.e., any region mCERADSOT > 1.5), VR was in agreement in 89.3% of cases, with 13 true negatives, 12 true positives, and 3 false positives (FP). Regional sparse-to-moderate neuritic and substantial diffuse Aβ plaque was observed in all FP cases. Regional VR was also associated with regional plaque density. CONCLUSION: VR is an appropriate method for assessing early amyloid pathology and that grading the extent of visual amyloid positivity could present clinical value.
引用
- Collij LE, Salvadó G, Shekari M, et al. Visual assessment of [18F]flutemetamol PET images can detect early amyloid pathology and grade its extent. Eur J Nucl Med Mol Imaging. 2021. PMID: 33615397. doi:10.1007/s00259-020-05174-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。